ES552559A0 - Procedimiento para la obtencion de imidazoles sustituidos - Google Patents

Procedimiento para la obtencion de imidazoles sustituidos

Info

Publication number
ES552559A0
ES552559A0 ES552559A ES552559A ES552559A0 ES 552559 A0 ES552559 A0 ES 552559A0 ES 552559 A ES552559 A ES 552559A ES 552559 A ES552559 A ES 552559A ES 552559 A0 ES552559 A0 ES 552559A0
Authority
ES
Spain
Prior art keywords
procedure
substituted imidazoles
obtaining substituted
obtaining
imidazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES552559A
Other languages
English (en)
Other versions
ES8705397A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8705397A1 publication Critical patent/ES8705397A1/es
Publication of ES552559A0 publication Critical patent/ES552559A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES552559A 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos Expired ES8705397A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH698883 1983-12-30

Publications (2)

Publication Number Publication Date
ES8705397A1 ES8705397A1 (es) 1987-05-01
ES552559A0 true ES552559A0 (es) 1987-05-01

Family

ID=4318179

Family Applications (6)

Application Number Title Priority Date Filing Date
ES539204A Expired ES8800166A1 (es) 1983-12-30 1984-12-28 Procedimiento para la obtencion de imidazoles sustituidos
ES552555A Expired ES8705394A1 (es) 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos
ES552557A Expired ES8705224A1 (es) 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos
ES552558A Expired ES8705396A1 (es) 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos
ES552556A Expired ES8705395A1 (es) 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos
ES552559A Expired ES8705397A1 (es) 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos

Family Applications Before (5)

Application Number Title Priority Date Filing Date
ES539204A Expired ES8800166A1 (es) 1983-12-30 1984-12-28 Procedimiento para la obtencion de imidazoles sustituidos
ES552555A Expired ES8705394A1 (es) 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos
ES552557A Expired ES8705224A1 (es) 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos
ES552558A Expired ES8705396A1 (es) 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos
ES552556A Expired ES8705395A1 (es) 1983-12-30 1986-02-28 Procedimiento para la obtencion de imidazoles sustituidos

Country Status (15)

Country Link
EP (1) EP0149976A3 (es)
JP (1) JPS60158176A (es)
AU (1) AU569135B2 (es)
CA (1) CA1233828A (es)
DD (1) DD228249A5 (es)
DK (1) DK614384A (es)
ES (6) ES8800166A1 (es)
FI (1) FI845140L (es)
GR (1) GR82625B (es)
HU (1) HU193916B (es)
IL (1) IL73955A (es)
NO (1) NO845278L (es)
NZ (1) NZ210722A (es)
PT (1) PT79761B (es)
ZA (1) ZA8410105B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200947B1 (de) 1985-04-26 1990-09-12 F. Hoffmann-La Roche Ag 1,3-Disubstituierte Imidazoliumsalze
JPS62103068A (ja) * 1985-09-23 1987-05-13 ヘキスト・アクチエンゲゼルシヤフト アリ−ルメチルアゾ−ルおよびそれらの塩ならびにそれらの製法
DE3628545A1 (de) * 1985-09-23 1987-04-23 Hoechst Ag Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
DE3707151A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag 1-(1-aryl-2-hydroxy-ethyl)-imidazole und deren salze, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
DE3812483A1 (de) * 1987-06-27 1989-01-05 Bayer Ag (azolyl-vinyl)-phenol-alkenylether
JPH03130266A (ja) * 1989-07-28 1991-06-04 Hodogaya Chem Co Ltd 置換フェニルアルキルイミダゾール誘導体
DE3931554A1 (de) * 1989-09-22 1991-04-04 Hoechst Ag (+)-(2-hydroxy-2-adamantyl)-1-imidazolyl-3- tolyl-methan und dessen salze, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung
JP3938651B2 (ja) * 2000-04-13 2007-06-27 セントラル硝子株式会社 光学活性α−メチル−ビス−3、5−(トリフルオロメチル)ベンジルアミンの製造方法
DE10032335A1 (de) * 2000-07-04 2002-01-17 Cognis Deutschland Gmbh Dimethylbenzol-Derivate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1487326A (fr) * 1966-01-18 1967-07-07 Clin Byla Ets Dérivés imidazoliques et leur préparation
IE40911B1 (en) * 1974-04-11 1979-09-12 Schering Ag Imidazole derivatives and process for their manufacture
DE2546064A1 (de) * 1975-10-10 1977-04-21 Schering Ag Triazolderivate und verfahren zu ihrer herstellung
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums

Also Published As

Publication number Publication date
FI845140L (fi) 1985-07-01
ES552556A0 (es) 1987-05-01
JPS60158176A (ja) 1985-08-19
ES552557A0 (es) 1987-05-01
ES8705397A1 (es) 1987-05-01
HU193916B (en) 1987-12-28
ES552555A0 (es) 1987-05-01
NO845278L (no) 1985-07-01
DK614384A (da) 1985-07-01
AU569135B2 (en) 1988-01-21
FI845140A0 (fi) 1984-12-27
ES8705396A1 (es) 1987-05-01
EP0149976A3 (de) 1986-12-10
ES539204A0 (es) 1987-10-16
AU3723584A (en) 1985-07-04
PT79761A (en) 1985-01-01
ES8800166A1 (es) 1987-10-16
HUT36463A (en) 1985-09-30
ES552558A0 (es) 1987-05-01
ZA8410105B (en) 1985-08-28
GR82625B (en) 1985-05-07
ES8705395A1 (es) 1987-05-01
DK614384D0 (da) 1984-12-20
EP0149976A2 (de) 1985-07-31
NZ210722A (en) 1987-06-30
IL73955A0 (en) 1985-03-31
IL73955A (en) 1988-09-30
ES8705224A1 (es) 1987-05-01
ES8705394A1 (es) 1987-05-01
DD228249A5 (de) 1985-10-09
CA1233828A (en) 1988-03-08
PT79761B (en) 1986-12-10

Similar Documents

Publication Publication Date Title
ES539783A0 (es) Procedimiento para la obtencion de 5-amino-1-fenil-pirazolessustituidos
ES541662A0 (es) Procedimiento para preparar nuevos imidazoles
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES535534A0 (es) Procedimiento para la obtencion de -aril-1h-azol-1-etanoles
ES542947A0 (es) Procedimiento para la obtencion de derivados piperazinicos
ES539204A0 (es) Procedimiento para la obtencion de imidazoles sustituidos
ES526042A0 (es) Procedimiento para la obtencion de azolilbutanoles
ES537829A0 (es) Procedimiento para la obtencion de compuestos de eglina
ES532240A0 (es) Procedimiento para la obtencion de benzoil-ureas.
ES533988A0 (es) Procedimiento para la obtencion de mercaptocarboxilamidas
ES528654A0 (es) Procedimiento para la obtencion de derivados de tetrahidrocarbazol
ES525257A0 (es) Procedimiento para la obtencion de poliamido-imidas
ES544511A0 (es) Procedimiento para la obtencion de fenoxialquilaminopropano-les substituidos
ES543387A0 (es) Procedimiento para la obtencion de pirazolin-5-onas susti- tuidas
ES527054A0 (es) Procedimiento para la obtencion de derivados bis-quinazolinicos
ES529763A0 (es) Procedimiento para la obtencion de hidantoinas n-sulfeniladas
ES534947A0 (es) Procedimiento para la obtencion de 2-(1-indolinil-metil)-imidazolinas
ES534221A0 (es) Procedimiento para la obtencion de pirrolidinonas
ES532635A0 (es) Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas
ES546551A0 (es) Procedimiento para la obtencion de arisulfonilguanidinas sustituidas
ES537129A0 (es) Procedimiento para la obtencion de iodacetamidas
ES535291A0 (es) Procedimiento para la obtencion de agentes termosensibilizadores
ES538169A0 (es) Procedimiento para la obtencion de carboximetilesteres
ES523448A0 (es) Procedimiento para la obtencion de n-metil-1-metiltio-2-nitroetenamina
ES527567A0 (es) Procedimiento para la obtencion de derivados de pirano-pirazol